AVTXVSMRNA• 12 Months (Normalized)
AVTX vs MRNA (Avalo Therapeutics Inc. vs Moderna Inc.)
Showing Closing Date Range from Sep, 17, 2025 to Sep, 17, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.69
+47.31%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
MRNA Performance $157.39
+529.57%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-482.26%
MRNA outperforming by 482.26%
AVTXMRNA
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | AVTX Price | AVTX Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 17, 2026 | $16.69 | +47.31% | $157.39 | +529.57% | -482.26% |
| Sep 16, 2026 | $16.58 | +46.34% | $145.62 | +482.48% | -436.14% |
| Sep 15, 2026 | $16.07 | +41.84% | $143.77 | +475.08% | -433.24% |
| Sep 14, 2026 | $16.18 | +42.81% | $146.69 | +486.76% | -443.95% |
| Sep 11, 2026 | $16.12 | +42.28% | $143.97 | +475.88% | -433.60% |
| Sep 10, 2026 | $17.18 | +51.63% | $136.62 | +446.48% | -394.85% |
| Sep 09, 2026 | $18.21 | +60.72% | $135.61 | +442.44% | -381.72% |
| Sep 08, 2026 | $19.71 | +73.96% | $140.33 | +461.32% | -387.36% |
| Sep 04, 2026 | $19.23 | +69.73% | $145.55 | +482.20% | -412.47% |
| Sep 03, 2026 | $19.00 | +67.70% | $148.87 | +495.48% | -427.78% |
| Sep 02, 2026 | $19.34 | +70.70% | $150.81 | +503.24% | -432.54% |
| Sep 01, 2026 | $18.95 | +67.26% | $154.27 | +517.08% | -449.82% |
| Aug 31, 2026 | $19.34 | +70.70% | $140.34 | +461.36% | -390.66% |
| Aug 28, 2026 | $19.59 | +72.90% | $137.99 | +451.96% | -379.06% |
| Aug 27, 2026 | $20.05 | +76.96% | $142.77 | +471.08% | -394.12% |
Page 1 of 17